Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.
Overview
- Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
- Centre for Neuromuscular Disease, University of Ottawa, Ottawa, ON K1H 8M5, Canada
- NeuroMuscular Centre, The Ottawa Hospital, Ottawa, ON K1Y4E9, Canada
- Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B3P4, Canada
- Inflammation and Chronic Disease Program, Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
- School of Pharmaceutical Sciences, University of Ottawa, Ottawa, ON K1H 8M5, Canada
- Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada
- Department of Pediatrics, Children’s Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON K1H 8L1, Canada
- Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON K1H 8L6, Canada
- Neuroscience Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
- Department of Genetics, Children’s Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1016/j.omta.2026.201757.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Authors: added Robin J. Parks (0000-0002-4959-2233); removed Robin J. Parks
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 6 keywords, 3 funders, 129 references.
Cite
This paper
Poulin, K. L., René, C. A., Smith, I. C., Vacratsis, P. O., Burger, D., McMillan, H. J., Kothary, R., Perkins, T. J., Warman-Chardon, J., & Parks, R. J. (2026). Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy. Molecular therapy. Advances, 34(2), 201757. https://
BibTeX
@article{poulin2026extra
author = {Poulin, Kathy L. and René, Charlotte A. and Smith, Ian C. and Vacratsis, Panayiotis O. and Burger, Dylan and McMillan, Hugh J. and Kothary, Rashmi and Perkins, Theodore J. and Warman-Chardon, Jodi and Parks, Robin J.},
title = {{Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy}},
journal = {Molecular therapy. Advances},
year = {2026},
month = may,
volume = {34},
number = {2},
pages = {201757},
publisher = {American Society of Gene \& Cell Therapy},
issn = {3117-387X},
doi = {10.1016/
url = {https://
pmid = {42232219},
pmcid = {PMC13224364}
}
RIS
TY - JOUR
AU - Poulin, Kathy L.
AU - René, Charlotte A.
AU - Smith, Ian C.
AU - Vacratsis, Panayiotis O.
AU - Burger, Dylan
AU - McMillan, Hugh J.
AU - Kothary, Rashmi
AU - Perkins, Theodore J.
AU - Warman-Chardon, Jodi
AU - Parks, Robin J.
TI - Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy
T2 - Molecular therapy. Advances
J2 - Mol Ther Adv
PY - 2026
DA - 2026/
VL - 34
IS - 2
SP - 201757
SN - 3117-387X
PB - American Society of Gene & Cell Therapy
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy",
"container-title": "Molecular therapy. Advances",
"author": [
{
"family": "Poulin",
"given": "Kathy L."
},
{
"family": "René",
"given": "Charlotte A."
},
{
"family": "Smith",
"given": "Ian C."
},
{
"family": "Vacratsis",
"given": "Panayiotis O."
},
{
"family": "Burger",
"given": "Dylan"
},
{
"family": "McMillan",
"given": "Hugh J."
},
{
"family": "Kothary",
"given": "Rashmi"
},
{
"family": "Perkins",
"given": "Theodore J."
},
{
"family": "Warman-Chardon",
"given": "Jodi"
},
{
"family": "Parks",
"given": "Robin J."
}
],
"container-title-short":
"volume": "34",
"issue": "2",
"page": "201757",
"DOI": "10.1016/
"PMID": "42232219",
"PMCID": "PMC13224364",
"ISSN": "3117-387X",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
13
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1126/science.adg6518 [code]
- Base editing rescue of spinal muscular atrophy in cells and in mice.Journal: Science (New York, N.Y.)In common: other condition, 13 references
- [2] doi:10.1016/j.xcrm.2024.101659 [code]
- Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation.Journal: Cell reports. MedicineIn common: other condition, 11 references
- [3] doi:10.1002/1873-3468.70303
- Organ-specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides.Journal: FEBS lettersIn common: other condition, 10 references
- [4] doi:10.1038/s41467-026-73545-8
- Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.Journal: Nature communicationsIn common: other condition, 9 references
- [5] doi:10.1038/s44321-025-00303-6
- Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy.Journal: EMBO molecular medicineIn common: other condition, 8 references
- [6] doi:10.1007/s00401-024-02709-x
- Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy.Journal: Acta neuropathologicaIn common: genetics / omics, other condition, 7 references
- [7] doi:10.1002/jev2.12397
- Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies.Journal: Journal of extracellular vesiclesIn common: 7 references
- [8] doi:10.1016/j.isci.2025.112461 [code]
- Comprehensive analysis across &
lt;i& gt;SMN2& lt;/ i& gt; excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophy. Journal: iScienceIn common: genetics / omics, other condition, 6 references - [9] doi:10.1038/s41413-025-00473-6
- SMN deficiency inhibits endochondral ossification via promoting TRAF6-induced ubiquitination degradation of YBX1 in spinal muscular atrophy.Journal: Bone researchIn common: genetics / omics, other condition, 6 references
- [10] doi:10.1172/jci.insight.158380
- Bap1/
SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system. Journal: JCI insightIn common: 6 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
